Establishing a Robotics Laboratory in Pharmaceuticals
Author Information
Author(s): Steve Conder
Primary Institution: Bristol-Myers Squibb Company
Conclusion
The establishment of a robotics laboratory at Bristol-Myers Squibb has improved the efficiency of Phase III stability studies through automation.
Supporting Evidence
- The laboratory has a capacity to handle more than 15,000 samples annually.
- Key issues for success include personnel selection, methods development, and routine assay support.
- The laboratory has shifted focus from late-stage to early-stage development projects.
Takeaway
This study talks about how using robots in a lab can help test medicines faster and better, especially when there are a lot of samples to check.
Methodology
The laboratory uses nine robotic systems to automate assays for stability studies, focusing on potency, dissolution, and moisture content.
Potential Biases
Potential biases may arise from the reliance on automated systems and the need for user education.
Limitations
The study does not provide specific data on the limitations of the robotics laboratory's performance over time.
Participant Demographics
The laboratory staff consists of eight individuals, including system managers and chemical technicians.
Want to read the original?
Access the complete publication on the publisher's website